SCHEMBL12117351

SCHEMBL12117351

CC1(C)c2ccccc2-c2cc3c(cc21)c1cc(C(=O)c2ccccc2)ccc1n3-c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 2/20 0.42
▸ CNR2 P34972 1/20 0.41
▸ SMN1; SMN2 Q16637 5/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ GLA P06280 1/20 0.40
▸ HPGD P15428 4/20 0.37
▸ KDM4E B2RXH2 2/20 0.35
▸ PGR P06401 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ HSD17B10 Q99714 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ GFER P55789 1/20 0.34
▸ MAPT P10636 3/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12117341 0.94 PDK2 (0.43) PDK2CNR2SMN1; SMN2ALDH1A1GLA
SCHEMBL803044 0.94 PDK2 (0.38) PDK2CNR2SMN1; SMN2ALDH1A1GLA
SCHEMBL12116382 0.89 CNR2 (0.43) PDK2CNR2SMN1; SMN2ALDH1A1GLA
SCHEMBL2603612 0.88 PDK2 (0.36) PDK2CNR2SMN1; SMN2ALDH1A1GLA
SCHEMBL12116386 0.87 PDK2 (0.43) PDK2CNR2SMN1; SMN2ALDH1A1GLA
SCHEMBL782532 0.87 PDK2 (0.37) PDK2CNR2SMN1; SMN2ALDH1A1GLA
SCHEMBL2603611 0.85 CNR2 (0.37) PDK2CNR2ALDH1A1KDM4EATM
SCHEMBL16919334 0.85 PGR (0.42) ALDH1A1KDM4EPGRATML3MBTL1
SCHEMBL2603515 0.85 PDK2 (0.38) PDK2CNR2SMN1; SMN2ALDH1A1GLA
SCHEMBL2603601 0.85 CNR2 (0.38) PDK2CNR2ALDH1A1KDM4EATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9475792-B2 Materials for organic electroluminescence devices MERCK PATENT GMBH (DE) 2016-10-25 — — US disclosed
US-9475792-B2 Materials for organic electroluminescence devices MERCK PATENT GMBH (DE) 2016-10-25 — — US disclosed
US-20110272684-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2011-11-10 — — US disclosed
US-20110272684-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2011-11-10 — — US disclosed
WO-2010083872-A2 MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2010-07-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110272684-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES SLCO4C1, SLCO2A1, SLCO1A2 PDK2 2096/4885CNR2 3674/4885SMN1; SMN2 3877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback